Loading the records…
Loading the records…
Leidos Holdings ($LDOS) received a $484M delivery order from NIH to support National Cancer Institute operations for FY26-FY27. This represents approximately 1.6% of Leidos' annual revenue, reinforcing its role in federal healthcare IT and research support.
The contract underscores the federal government's continued investment in cancer research infrastructure. For $LDOS, this adds predictable revenue through 2027. The broader healthcare IT sector may see similar opportunities as NIH maintains its operational support contracts.
The Department of Health and Human Services, through the National Institutes of Health, awarded a $484M delivery order to Leidos Biomedical Research Inc. for operational support of the National Cancer Institute over fiscal years 2026-2027. This task order covers a two-year period and is a continuation of Leidos' long-standing support for NCI operations. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. ($LDOS), a publicly traded technology and engineering company with $15.3B in annual revenue (FY2025). The $484M award translates to roughly $242M per year, or about 1.6% of Leidos' top line—a meaningful but not transformative contribution. No directly related legislation was identified among the provided bill signals; the contract appears to be a routine operational renewal funded through existing appropriations. Subcontractor details are not publicly available, but Leidos typically engages a network of small and mid-sized IT and research support firms for such task orders. Historically, Leidos has consistently won large NIH task orders, contributing to steady revenue growth in its health segment without causing major stock price swings given the company's size and diversification.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Direct award of delivery order to subsidiary Leidos Biomedical Research Inc.
Who must act
Department of Health and Human Services (NIH) awarding to Leidos Biomedical Research Inc.
What happens
$484M added to backlog over two years, representing approximately $242M per year or 1.6% of annual revenue.
Stock impact
Leidos is a diversified technology and engineering company; this contract reinforces its position in federal health IT and biomedical research support, a core segment of its health business.
Matched on shared policy language across AI analyses, with ticker & timing weight
LEIDOS BIOMEDICAL RESEARCH INC: $484M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $485M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $826M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $338M Department of Health and Human Services Contract
Executive orders & memoranda affecting the same sectors or companies
This proclamation reaffirms U.S. leadership in space exploration, declaring outer space open to development and permanent settlement by American citizens. It sets goals for a return to the Moon by 2028 and a future Mars mission, while emphasizing support for the commercial space industry. The action does not invoke specific legal authorities or direct new funding but signals continued policy focus on space.
The President invokes Section 232 of the Trade Expansion Act to declare that imports of robotics, industrial machinery, and their components threaten national security, and directs the Secretary of Commerce and USTR to negotiate agreements with trading partners to adjust these imports, potentially leading to tariffs or quotas within 180 days.
This proclamation initiates negotiations to adjust imports of wind turbines and their components under Section 232, citing national security concerns including cybersecurity vulnerabilities, radar interference, and grid reliability. It does not immediately impose tariffs but sets the stage for potential trade restrictions, and notes that certain wind turbine components made of aluminum, steel, or copper are already subject to existing tariffs.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →